Here’s why two coronavirus vaccine candidates failing in clinical trials is actually good news,

The Sanofi/GSK drug failed to elicit an effective immune response in people older than 49. The two companies will start a new trial in February, and their …, The Sanofi/GSK drug failed to elicit an effective immune response in people older than 49. The two companies will start a new trial in February, and their …, Read More